conley6.gif (2529 bytes)

 


Deadliest cancers
Lack of warning signs makes some cancers more difficult to detect during early stages of the disease

By CATHY BREITENBUCHER

November 18, 2009

By now everyone knows about the importance of regular mammograms, Pap smears and colonoscopies. Such screenings can detect cancers early, when they are most treatable.

Some cancers, however, not only lack a routine testing system, but also have few warning signs or symptoms.

Leukemias, along with lung, pancreatic, ovarian and brain are the cancers experts call the most dangerous in adults.

"One feature of these cancers that is important is they are fairly sneaky," says Dr. S. Vance Strother, medical oncologist with Wheaton Franciscan Healthcare. "They can reach a good size before it’s known."

That’s what happened to Kathi Mullenberg. Her lung cancer already was inoperable when it was discovered in August 2007. Mullenberg, 47, initially saw her doctor due to menstrual irregularities and underwent several tests.

She had been a pack-a-day smoker since age 15 and had an extensive family history of cancer. Still, when her Caller ID display read "Oncology," Mullenberg was sent reeling. "I don’t know the words to explain how I felt," she says.

Chemotherapy and radiation have reduced her tumor’s size by two-thirds and dramatically slowed its growth. Although unable to return to work, Mullenberg feels well enough to do light exercise, go camping and attend her two daughters’ school activities.

"Somebody’s on my side up there," she says. "My whole thing was to keep positive for the girls."

Doctors and patients alike say that strong connections with family and friends can contribute to a patient’s positive attitude in the face of unfavorable odds.

"Spiritual wellness and support networks are things you can characterize but not quantify. They certainly can’t hurt," says Dr. Peter H. Johnson, medical oncologist and hematologist at ProHealth Care’s Regional Cancer Center. "One thing I like to emphasize to folks is what (projected survival time) they are given is an average, and they themselves are not average. By definition, half do better and half do worse."

After her pancreatic cancer diagnosis in February, retiree Harriet Russell, 68, found support literally in her own backyard. When spring came and she was undergoing chemotherapy and radiation (and preparing for surgery), she recruited friends to plant 30 pots of flowers and several garden areas at her River Hills home.

"I got to see everything come to life. Now, I do the weeding, pull hoses and do some lifting, which is helping me build muscle," explains Russell, whose chemo is scheduled to last until about December.

However, another pancreatic cancer survivor, Peggy Barager of Wauwatosa, says it is unrealistic to expect a patient to be positive all the time. About once a month, she withdraws to "cry and watch mindless stuff on TV for two days."

While Barager, 57, does lean on TV, she has kept the promise she made to herself when she was diagnosed in December: to not read any cancer information online. "I knew what was out there would scare the beejeebers out of me," she says. "I decided I’d save all my questions and ask my doctor."

Researchers, meanwhile, are trying to develop more diagnostic tests and figuring out which patients could benefit the most from each type of test. Testing only those at highest risk, for instance, would catch just 25 percent of pancreatic cancers, according to Dr. Douglas Evans, Froedtert & The Medical College of Wisconsin pancreatic cancer specialist.

"Anything short of a blood test (for large patient populations) is just not going to do it for pancreatic cancer," he adds.

Then there’s the difference between finding cancer and actually treating it successfully. "Our capacity to detect cancer early isn’t by itself sufficient to warrant screening if we can’t change the outcome," warns Johnson.

With analysis of the DNA of the tumor and identification of genetic markers carried by the patient, treatment is personalized.

"The direction is we will use less and less chemo and use more medications that help cancer cells die off or reproduce more slowly," predicts Dr. Gilberto Rodrigues, a general cancer and lung cancer specialist with Oncology Alliance. "Ideally, you want to find out what made the cancer cell develop and ask, ‘What is the antidote?’"

In other words, cancer some day might be viewed as a chronic condition rather than a life-threatening disease.

"How well and how long people survive, not whether the cancer shrinks, is really the bottom line. Then we’re looking at a stable disease," says Strother. "If the growth isn’t reversed but is arrested, that’s a pretty good result." 

Be Your Own Watchdog

An annual physical is one way to keep tabs on your health. Day to day, know your body. You might detect a problem that could mean cancer. Watch for:

• A bloated feeling or fluid buildup in the abdomen (a common symptom of ovarian cancer).

• Unexplained weight loss.

• Unexplained pain.

• Loss of energy, dizzy spells.

• Fever (can indicate leukemia or lymphoma).

• Headaches that don’t respond to treatment (might mean a brain tumor).

• Severe night sweats for men or nonmenopausal women.

• Jaundice (yellowed) or itchy skin (could indicate pancreatic cancer).

• Elevated blood sugar (in someone who does not have diabetes).

"If a symptom doesn’t get better in a couple weeks, that’s not normal. They should seek medical advice," says Dr. Gilberto Rodrigues.

Getting answers

Because her father and brother both died of pancreatic cancer, Betty Ratchek of Twin Lakes jumped at the chance to learn whether she was at risk.

As part of the new Familial Pancreatic Cancer Initiative at Aurora St. Luke’s Medical Center, Ratchek underwent genetic testing and had an ultrasound that looked at the pancreas through the wall of the stomach.

"My doctor said, ‘You have an opportunity most people don’t have,’" she says.

The ultrasound showed that Ratchek, 66, had pancreatic cancer — but at an early, treatable stage. She also learned that she and her daughters carry the BRCA2 gene, likely explaining why she and one daughter have had breast cancer. As a precautionary measure, her other daughter has undergone a bilateral mastectomy.

 

 


This story ran in the October 2009 issue of: